Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-κB activity in lipopolysaccharide-activated human primary monocytes

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5423-5429

  Lu, Yunbiao ^a   Wahl, Larry M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERSTITIAL COLLAGENASE; LACTACYSTIN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; WESTERN BLOTTING;

EID: 26844522332     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5423     Document Type: Article

References (50)

1. Jones, D. 2004. Reactive oxygen species and rosacea. Cutis 74: 17-20.
2. Victor, V. M., M. Rocha, and M. De la Fuente. 2004. Immune cells: free radicals and antioxidants in sepsis. Int. Immunopharmacol. 4: 327-347.
3. Lassegue, B., and K. K. Griendling. 2004. Reactive oxygen species in hypertension: an update. Am. J. Hypertens. 17: 852-860.
4. Andreadis, A. A., S. L. Hazen, S. A. Comhair, and S. C. Erzurum. 2003. Oxidative and nitrosative events in asthma. Free Radical Biol. Med. 35: 213-225.
5. Rahman, I. 2002. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr. Drug Targets Inflamm. Allergy 1: 291-315.
6. Henrotin, Y. E., P. Bruckner, and J. P. Pujol. 2003. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11: 747-755.
7. Li, J. M., and A. M. Shah. 2004. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. 287: R1014-R1030.
8. Milla, C., S. Yang, D. N. Cornfield, M. L. Brennan, S. L. Hazen, A. Panoskaltsis-Mortari, B. R. Blazar, and I. Y. Haddad. 2004. Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am. J. Physiol. 287: L706-L714.
9. Finkel, T. 1998. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10: 248-253.
10. El Bekay, R., M. Alvarez, J. Monteseirin, G. Alba, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Pintado, F. J. Bedoya, et al. 2003. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB. Blood 102: 662-671.
11. Melo, R. C., D. L. Fabrino, H. D'Avila, H. C. Teixeira, and A. P. Ferreira. 2003. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol. Int. 27: 853-861.
12. Hadjigogos, K. 2003. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med. 45: 7-13.
13. Allen, R. G., and M. Tresini. 2000. Oxidative stress and gene regulation. Free Radical Biol. Med. 28: 463-499.
14. Stetler-Stevenson, W. G., and A. E. Yu. 2001. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 11: 143-152.
15. Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494.
16. Sternlicht, M. D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17: 463-516.
17. Wahl, L. M., and L. L. Lampel. 1987. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. Cell. Immunol. 105: 411-422.
18. 2 synthesis. J. Invest. Dermatol. 104: 52-57.
19. Shankavaram, U. T., D. L. DeWitt, S. E. Funk, E. H. Sage, and L. M. Wahl. 1997. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell. Physiol. 173: 327-334.
20. Shapiro, S. D., D. K. Kobayashi, A. P. Pentland, and H. G. Welgus. 1993. Induction of macrophage metalloproteinases by extracellular matrix: evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268: 8170-8175.
21. Busiek, D. F., V. Baragi, L. C. Nehring, W. C. Parks, and H. G. Welgus. 1995. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154: 6484-6491.
22. Astiz, M., D. Saha, D. Lustbader, R. Lin, and E. Rackow. 1996. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J. Lab. Clin. Med. 128: 594-600.
23. Meade, E. A., W. L. Smith, and D. L. DeWitt. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610-6614.
24. Dubois, R. N., S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. Van De Putte, and P. E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073.
25. Baker, C. S., R. J. Hall, T. J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M. H. Yacoub, and J. M. Polak. 1999. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler. Thromb. Vasc. Biol. 19: 646-655.
26. Schonbeck, U., G. K. Sukhova, P. Graber, S. Coulter, and P. Libby. 1999. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am. J. Pathol. 155: 1281-1291.
27. Lai, W. C., M. Zhou, U. Shankavaram, G. Peng, and L. M. Wahl. 2003. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170: 6244-6249.
28. Mertz, P. M., D. L. DeWitt, W. G. Stetler-Stevenson, and L. M. Wahl. 1994. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269: 21322-21329.
29. Plummer, S. M., K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells. 1999. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene 18: 6013-6020.
30. Allen, R. G. 1991. Oxygen-reactive species and antioxidant responses during development: the metabolic paradox of cellular differentiation. Proc. Soc. Exp. Biol. Med. 196: 117-129.
31. Forman, H. J., and M. Torres. 2001. Redox signaling in macrophages. Mol. Aspects Med. 22: 189-194.
32. Urban, M. B., R. Schreck, and P. A. Baeuerle. 1991. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10: 1817-1825.
33. Schreck, R., K. Albermann, and P. A. Baeuerle. 1992. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Res. Commun. 17: 221-237.
34. 2 in NF-κB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272: 25941-25950.
35. Lakshminarayanan, V., E. A. Drab-Weiss, and K. A. Roebuck. 1998. H2O2 and tumor necrosis factor-á induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273: 32670-32678.
36. Anderson, M. T., F. J. Staal, C. Gitler, and L. A. Herzenberg. 1994. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA 91: 11527-11531.
37. Brennan, P., and L. A. O'Neill. 1995. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260: 167-175.
38. Israel, N., M. A. Gougerot-Pocidalo, F. Aillet, and J. L. Virelizier. 1992. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149: 3386-3393.
39. Ginn-Pease, M. E., and R. L. Whisler. 1998. Redox signals and NF-κB activation in T cells. Free Radical Biol. Med. 25: 346-361.
40. Pahlavani, M. A., and M. D. Harris. 1998. Effect of in vitro generation of oxygen free radicals on T cell function in young and old rats. Free Radical Biol. Med. 25: 903-913.
41. Carballo, M., G. Marquez, M. Conde, J. Martin-Nieto, J. Monteseirin, J. Conde, E. Pintado, and F. Sobrino. 1999. Characterization of calcineurin in human neutrophils: inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-κB DNA binding. J. Biol. Chem. 274: 93-100.
42. Takada, Y., A. Mukhopadhyay, G. C. Kundu, G. H. Mahabeleshwar, S. Singh, and B. B. Aggarwal. 2003. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278: 24233-24241.
43. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60: 4053-4057.
44. Bae, Y. S., S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock, and S. G. Rhee. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272: 217-221.
45. Monteiro, H. P., Y. Ivaschenko, R. Fischer, and A. Stern. 1991. Inhibition of protein tyrosine phosphatase activity by diamide is reversed by epidermal growth factor in fibroblasts. FEBS Lett. 295: 146-148.
46. Denu, J. M., and K. G. Tanner. 1998. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633-5642.
47. Poli, G., G. Leonarduzzi, F. Biasi, and E. Chiarpotto. 2004. Oxidative stress and cell signalling. Curr. Med. Chem. 11: 1163-1182.
48. Vincenti, M. P., and C. E. Brinckerhoff. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4: 157-164.
49. Chase, A. J., M. Bond, M. F. Crook, and A. C. Newby. 2002. Role of nuclear factor-κB activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler. Thromb. Vasc. Biol. 22: 765-775.
50. Rockwell, P., J. Martinez, L. Papa, and E. Gomes. 2004. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell. Signal. 16: 343-353.